NP falsely claimed that the CCR5 occupancy test by

Quote:

---

NP falsely claimed that the CCR5 occupancy test by Incelldx wasn’t FDA approved (or something along those lines).

---

I think it was more along the lines of "wasn't accepted". The CCR5 occupancy tests being used were not the standard occupancy test. That was one based on leronlimab which was developed and patented by Dr. Patterson. Not being familiar with that particular test the FDA may have rejected it on that basis.